468

What type and quantity of clinical evidence is required by payers in formulating positive coverage policies for products and procedures?

If you don’t have a clear answer, you’re not alone. As a board member of the Alliance of Wound Care Stakeholders, I invite you to our upcoming Wound Care Evidence Summit – a unique opportunity to solve this and other evidence/coverage challenges together with government and commercial payers, Federal policymakers and regulators, researchers, medical societies, and manufacturers.

Click here to grab your spot today.

–Caroline

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.